4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
ProMIS Neurosciences, Inc. (PMN) operates in the Biotechnology industry and is headquartered in Toronto, Canada with about 10 employees. Its market capitalization is roughly $136 million. In the fiscal year ended 2025-12-31, PMN reported $0M in revenue and ($40M) in net income.
ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($40M) | ($17M) | ($14M) | ($23M) | — |
| Net Income | ($40M) | $3M | ($13M) | ($18M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($9M) | ($11M) | ($12M) | ($10M) | ($8M) | — |
| Net Income | ($8M) | ($11M) | ($12M) | ($10M) | ($7M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $9M | $19M | $14M | $7M | — |
| Total Liabilities | $10M | $2M | $10M | $8M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PMN viewer.
About TickerBase · Data methodology & sources